I think this thread has answered itself without realising it."why would the instos want to stop the retail offer being taken up by capping the price below the offer price?answerwhy would instos want any more retail scrip on board.ifandwhen
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%